Cargando…
Stakeholder knowledge and attitudes toward the use of predictive genetic testing in South Africa
The use of predictive genetic testing, particularly for risk profiling in non-communicable diseases (NCDs), has the potential to benefit public health by decreasing the disease burden and alleviating the pressure on healthcare. It is thus important to assess knowledge and uptake among stakeholders....
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462643/ https://www.ncbi.nlm.nih.gov/pubmed/36085342 http://dx.doi.org/10.1007/s12687-022-00606-y |
_version_ | 1784787232397197312 |
---|---|
author | Naidoo, Levani Reddy, Poovendhree |
author_facet | Naidoo, Levani Reddy, Poovendhree |
author_sort | Naidoo, Levani |
collection | PubMed |
description | The use of predictive genetic testing, particularly for risk profiling in non-communicable diseases (NCDs), has the potential to benefit public health by decreasing the disease burden and alleviating the pressure on healthcare. It is thus important to assess knowledge and uptake among stakeholders. This study aimed to assess end users’ (community, medical practitioners and medical students) knowledge and attitudes regarding the use and support of genomic medicine. A descriptive cross-sectional survey was conducted in Kwazulu-Natal (KZN) among 3 groups of stakeholders (n = 170): medical practitioners from both private and public healthcare, medical students from UKZN and community members represented by teachers. Three structured questionnaires using a Likert scale were administered. Responses were stratified by practice type, and a scoring scale was developed. Principal component analysis (PCA) was used to reduce data on all constructs that made up each variable. All three groups showed adequate knowledge and a positive attitude towards use, apart from medical students who were not as keen to support future use in their own practice. Although medical practitioners supported the use of this technology, with necessary guidelines, expertise and affordability, only 18% from private practice reported having used it. PCA reduced data to fewer parsimonious constructs for all 3 groups: common threads included an awareness that genetic testing may improve health and disease outcomes; guidelines for use; and the provision of education to increase awareness, training to bolster expertise and confidence to use these services. Participants in this study attributed a lack of uptake to limited expertise and professional support, and a lack of legislative guidelines. We recommend updating continuing professional development for medical practitioners and promoting community education concomitantly. Provision of guidelines and increased accessibility to resources are important. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12687-022-00606-y. |
format | Online Article Text |
id | pubmed-9462643 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-94626432022-09-10 Stakeholder knowledge and attitudes toward the use of predictive genetic testing in South Africa Naidoo, Levani Reddy, Poovendhree J Community Genet Original Article The use of predictive genetic testing, particularly for risk profiling in non-communicable diseases (NCDs), has the potential to benefit public health by decreasing the disease burden and alleviating the pressure on healthcare. It is thus important to assess knowledge and uptake among stakeholders. This study aimed to assess end users’ (community, medical practitioners and medical students) knowledge and attitudes regarding the use and support of genomic medicine. A descriptive cross-sectional survey was conducted in Kwazulu-Natal (KZN) among 3 groups of stakeholders (n = 170): medical practitioners from both private and public healthcare, medical students from UKZN and community members represented by teachers. Three structured questionnaires using a Likert scale were administered. Responses were stratified by practice type, and a scoring scale was developed. Principal component analysis (PCA) was used to reduce data on all constructs that made up each variable. All three groups showed adequate knowledge and a positive attitude towards use, apart from medical students who were not as keen to support future use in their own practice. Although medical practitioners supported the use of this technology, with necessary guidelines, expertise and affordability, only 18% from private practice reported having used it. PCA reduced data to fewer parsimonious constructs for all 3 groups: common threads included an awareness that genetic testing may improve health and disease outcomes; guidelines for use; and the provision of education to increase awareness, training to bolster expertise and confidence to use these services. Participants in this study attributed a lack of uptake to limited expertise and professional support, and a lack of legislative guidelines. We recommend updating continuing professional development for medical practitioners and promoting community education concomitantly. Provision of guidelines and increased accessibility to resources are important. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12687-022-00606-y. Springer Berlin Heidelberg 2022-09-09 2022-12 /pmc/articles/PMC9462643/ /pubmed/36085342 http://dx.doi.org/10.1007/s12687-022-00606-y Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
spellingShingle | Original Article Naidoo, Levani Reddy, Poovendhree Stakeholder knowledge and attitudes toward the use of predictive genetic testing in South Africa |
title | Stakeholder knowledge and attitudes toward the use of predictive genetic testing in South Africa |
title_full | Stakeholder knowledge and attitudes toward the use of predictive genetic testing in South Africa |
title_fullStr | Stakeholder knowledge and attitudes toward the use of predictive genetic testing in South Africa |
title_full_unstemmed | Stakeholder knowledge and attitudes toward the use of predictive genetic testing in South Africa |
title_short | Stakeholder knowledge and attitudes toward the use of predictive genetic testing in South Africa |
title_sort | stakeholder knowledge and attitudes toward the use of predictive genetic testing in south africa |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462643/ https://www.ncbi.nlm.nih.gov/pubmed/36085342 http://dx.doi.org/10.1007/s12687-022-00606-y |
work_keys_str_mv | AT naidoolevani stakeholderknowledgeandattitudestowardtheuseofpredictivegenetictestinginsouthafrica AT reddypoovendhree stakeholderknowledgeandattitudestowardtheuseofpredictivegenetictestinginsouthafrica |